Emergent BioSolutions to Participate in January 2015 Investor Conferences

ROCKVILLE, Md., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company's senior management team will participate in the following investor conferences in January 2015:

• 33rd Annual J.P. Morgan Healthcare Conference San Francisco January 12, 2015 Presentation: 8:00AM Pacific  
• Noble Financial Capital Markets' 11th Annual Investor/Equity Conference Florida January 20, 2015 Presentation: 3:00PM Eastern

The company will be webcasting its participation in these conferences, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under "Investors."

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.

CONTACT: Investors Contact:
         Robert G. Burrows
         Vice President, Investor Relations
         301-795-1877
         [email protected]

         Media Contact:
         Tracey Schmitt
         Vice President, Global Public Affairs
         and Corporate Responsibility
         301-795-1800
         [email protected]

You May Also Be Interested In

• Delta Air Lines stock climbs on earnings beat and strong guidance
• BTIG Starts Equinix (EQIX) at Buy
• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance